CRITICAL ISSUES OF PAPILLOMA VIRUS INFECTION PREVENTION
The article details the issue of malignancy caused by human papilloma virus (HPV), as well as characteristics of this virus. Its genetic stability allows for efficient prevention of this pathology through vaccination. 2 vaccines, which are approved by the FDA end EMEA for use and are registered in R...
Saved in:
| Main Authors: | E.V. Uvarova, Z.Kh. Kumykova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2011-01-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/742 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CERVICAL CANCER IS NOT A CHILDREN'S ILLNESS, ISN'T IT?
by: E.V. Uvarova, et al.
Published: (2009-06-01) -
HUMAN PAPILLOMA VIRUS. PREVENTION OF HPV-ASSOCIATED DISEASES
by: F. C. Shakhtakhtinskaya, et al.
Published: (2015-08-01) -
PRENATAL INFECTION AT THE HUMAN PAPILLOMA VIRUS INFECTION AT PREGNANT WOMEN
by: N. Yu. Katkova, et al.
Published: (2016-06-01) -
Pregnancy and the virus of human papilloma
by: O. V. Yakovleva, et al.
Published: (2021-06-01) -
HUMAN PAPILLOMA VIRUS — ONCOGENIC VIRUS
by: A.N. Mayansky
Published: (2010-07-01)